Genome-wide meta-analysis identifies novel multiple sclerosis susceptibility loci

Patsopoulos, Na; Esposito, F; Reischl, J; Lehr, S; Bauer, D; Heubach, J; Sandbrink, R; Pohl, C; Edan, G; Kappos, L; Miller, D; Montalbán, X; Polman, Ch; Freedman, Ms; Hartung, Hp; Arnason, Bgw; Comi, Giancarlo; Cook, S; Filippi, Massimo; Goodin, Ds; Jeffery, D; O'Connor, P; Ebers, Gc; Langdon, D; Reder, At; Traboulsee, A; Zipp, F; Schimrigk, J; Hillert, J; Bahlo, M; Booth, Dr; Broadleys, ; Brown, Ma; Browning, Bl; Browning, Sr; Butzkueven, H; Carroll, Wm; Chapman, C; Foote, Sj; Griffiths, L; Kermode, Ag; Kilpatrick, Tj; Lechner Scott, J; Marriott, M; Mason, D; Moscato, P; Heard, Rn; Pender, Mp; Perreau, Vm; Perera, D; Rubio, Jp; Scott, Rj; Slee, M; Stankovich, J; Stewart, Gj; Taylor, Bv; Tubridy, N; Willoughby, E; Wiley, J; Matthews, P; Boneschi, F; Compston, A; Haines, J; Hauser, Sl; Mccauley, J; Ivinson, A; Oksenberg, Jr; Pericak Vance, M; Sawcer, Sj; De Jager, Pl; Hafler, Da; de Bakker, Piw; the BSP MS Genetics working, Group; the steering committees of studies evaluating IFNb, 1b; A., CCR1 antagonist; Anzgene, Consortium; Genemsa, ; International Multiple Sclerosis Genetics, Consortium